Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Cancer Letters
|
June 14, 2024
The use of platelets as a clinical tool in oncology: opportunities and challenges
Sara Bravaccini, Elisa Boldrin, Giorgia Gurioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter
Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Michela Cortesi, Michele Zanoni, Francesca Pirini, et al.
International Journal of Environmental Research and Public Health
|
April 3, 2021
Expanding Roles of De Novo Lipogenesis in Breast Cancer
Pasquale Simeone, Stefano Tacconi, Serena Longo, et al.
Clinical Breast Cancer
|
March 24, 2020
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2<sup>+</sup> Early-stage Breast Cancer?
Roberta Maltoni, Michela Palleschi, Mattia Altini, et al.
Frontiers in Endocrinology
|
September 16, 2022
Androgen receptor in breast cancer: The "5W" questions
Sara Ravaioli, Roberta Maltoni, Barbara Pasculli, et al.
Journal of Oncology
|
May 22, 2019
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, et al.
Scientific Reports
|
May 8, 2021
Spotlight on PSMA as a new theranostic biomarker for bladder cancer
Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, et al.
Translational Oncology
|
December 5, 2021
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, et al.
Biomedicines
|
October 26, 2024
A Novel <i>AKT1</i>, <i>ERBB2</i>, <i>ESR1</i>, <i>KRAS</i>, <i>PIK3CA</i>, and <i>TP53</i> NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors
Alessandra Virga, Caterina Gianni, Michela Palleschi, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Cancer Letters
|
June 14, 2024
The use of platelets as a clinical tool in oncology: opportunities and challenges
Sara Bravaccini, Elisa Boldrin, Giorgia Gurioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter
Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Michela Cortesi, Michele Zanoni, Francesca Pirini, et al.
International Journal of Environmental Research and Public Health
|
April 3, 2021
Expanding Roles of De Novo Lipogenesis in Breast Cancer
Pasquale Simeone, Stefano Tacconi, Serena Longo, et al.
Clinical Breast Cancer
|
March 24, 2020
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2<sup>+</sup> Early-stage Breast Cancer?
Roberta Maltoni, Michela Palleschi, Mattia Altini, et al.
Frontiers in Endocrinology
|
September 16, 2022
Androgen receptor in breast cancer: The "5W" questions
Sara Ravaioli, Roberta Maltoni, Barbara Pasculli, et al.
Journal of Oncology
|
May 22, 2019
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, et al.
Scientific Reports
|
May 8, 2021
Spotlight on PSMA as a new theranostic biomarker for bladder cancer
Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, et al.
Translational Oncology
|
December 5, 2021
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, et al.
Biomedicines
|
October 26, 2024
A Novel <i>AKT1</i>, <i>ERBB2</i>, <i>ESR1</i>, <i>KRAS</i>, <i>PIK3CA</i>, and <i>TP53</i> NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors
Alessandra Virga, Caterina Gianni, Michela Palleschi, et al.
Page
of 15